Management of Intradialytic Hypotension
The primary approach to intradialytic hypotension is to modify the dialysis prescription itself through ultrafiltration optimization and dialysate adjustments, rather than relying on medications, as these interventions directly address the underlying pathophysiology without compromising dialysis adequacy. 1
Immediate Ultrafiltration Management
The most critical intervention is reassessing and adjusting ultrafiltration parameters:
Avoid excessive ultrafiltration by reevaluating the estimated dry weight (EDW). A key indicator that EDW may be set too low is improving nutritional markers (rising serum albumin, creatinine, or normalized protein catabolic rate) occurring alongside hypotensive episodes 1
Reduce ultrafiltration rate by extending treatment duration rather than simply removing less fluid. This maintains adequate dialysis while lowering the hourly rate 1
Consider sequential ultrafiltration/clearance where ultrafiltration is performed separately from diffusive clearance, though this requires extending total treatment time to compensate for lost clearance time 1
The evidence strongly supports keeping ultrafiltration rates below specific thresholds—rates exceeding 10 mL/h/kg are associated with worse outcomes, and rates above 13 mL/h/kg independently increase cardiovascular and all-cause mortality 2
Dialysate Modifications (First-Line Interventions)
These are simple, effective strategies implementable in most units:
1. Increase dialysate sodium concentration to 148 mEq/L, particularly early in the session, followed by stepwise reduction later ("sodium ramping"). This effectively reduces hypotension and cramping, though monitor for increased interdialytic weight gain and blood pressure 1
2. Switch from acetate to bicarbonate-buffered dialysate if not already using bicarbonate. Acetate inappropriately decreases vascular resistance and increases venous pooling, directly contributing to hypotension 1
3. Reduce dialysate temperature from 37°C to 34-35°C. This increases peripheral vasoconstriction and cardiac output through enhanced sympathetic tone, reducing symptomatic hypotension from 44% to 34% in studies. The benefit is greatest in patients with frequent hypotensive episodes 1. However, some patients experience intolerable symptomatic hypothermia 1
Pharmacologic Interventions (Second-Line)
Midodrine is the most widely used medication when non-pharmacologic measures fail. Administer within 30 minutes before dialysis initiation. It raises blood pressure by increasing peripheral vascular resistance and enhancing venous return through selective α1-adrenergic agonism. Studies demonstrate it minimizes hypotensive events, raises the lowest intradialytic blood pressure, and reduces required interventions 1. The drug is well-tolerated with few side effects, though availability is limited outside the United States 3
Alternative medications with weaker evidence include arginine-vasopressin, sertraline, droxidopa, fludrocortisone, and carnitine 3
Anemia and Oxygenation
- Correct anemia to ranges recommended by NKF-K/DOQI Anemia Guidelines 1
- Administer supplemental oxygen in patients with cardiovascular or respiratory disease, as clinical experience suggests this reduces hypotension incidence 1
Patient-Related Factors
Fluid intake management: Counsel patients to limit interdialytic weight gain. Excessive weight gain necessitates higher ultrafiltration rates, directly increasing hypotension risk 1
Food timing: Avoid food intake immediately before or during hemodialysis, as this decreases peripheral vascular resistance and precipitates hypotension 1
Antihypertensive medications: The evidence on withholding antihypertensives before dialysis is contradictory and currently under investigation in ongoing trials. Consider medication dialyzability—avoid nondialyzable agents in patients with frequent intradialytic hypotension 3. Individualize timing based on interdialytic blood pressure patterns and hypotension frequency 3
Critical Pitfalls to Avoid
Do not compromise dialysis adequacy: The common response of decreasing blood flow and ultrafiltration rates when hypotension occurs results in inadequate dialysis dose and unmet ultrafiltration goals 1. Instead, implement the preventive strategies above while maintaining prescribed treatment parameters
Recognize the clinical significance: Intradialytic hypotension causes premature treatment termination in 15% of cases and contributes to patient nonadherence, missed sessions, and exaggerated urea rebound 1. More importantly, repeated hypotensive episodes cause end-organ ischemia affecting the heart, brain, kidneys, and gastrointestinal system, ultimately increasing cardiovascular and all-cause mortality 4, 5
Emerging Interventions
Recent evidence suggests intermittent pneumatic compression during dialysis significantly reduces intradialytic hypotension occurrence with 94.2% adherence and satisfactory safety 6. This represents a promising non-pharmacologic adjunct when standard measures are insufficient.